Ultra High Sensitivity
Attomolar sensitivity for detection and baseline quantitation of critical biomarkers from non-invasive sample types as well as remote sampling devices.
High Specificity
Assays developed to detect individual isoforms and a variety of post-translational modifications. Antibodies are selected for reduced cross reactivity with known homologs.
Scalable Multiplex
Flexible, scalable chemistry provides the ability to focus in on a single target, or multiplex hundreds to potentially thousands of targets in a single sample on one platform.
Broad Dynamic Range
With single plex up to 7 logs and multiplex up to 12 logs of dynamic range, NULISA enables quantitation across a broad range of biological expression levels without the need for dilution.
Automation
Fully automated workflow with <30 minutes of total hands-on time, can processes up to 288 samples per run batch.
Single-plex results in ~8 hours and multiplex results in ~16 hours with <30 minutes total hands-on time with the ARGO™ HT System
Alamar Biosciences is a precision proteomics company focused on ultra-sensitive biomarker detection technologies for translational research, clinical studies, and precision medicine applications. Its proprietary NULISA™ and ARGO™ platforms combine attomolar sensitivity with high multiplexing to enable deep protein profiling from minimal sample volumes across neurology, oncology, immunology, and inflammatory disease research.
